2/20
01:11 pm
krtx
Karuna Therapeutics, Inc. (NASDAQ: KRTX) had its "neutral" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $330.00 price target on the stock.
Low
Report
Karuna Therapeutics, Inc. (NASDAQ: KRTX) had its "neutral" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $330.00 price target on the stock.
2/20
12:37 pm
krtx
Rating for KRTX
Low
Report
Rating for KRTX
1/26
08:45 am
krtx
Karuna Therapeutics, Inc. (NASDAQ: KRTX) had its "neutral" rating re-affirmed by analysts at Mizuho. They now have a $330.00 price target on the stock, up previously from $245.00.
Low
Report
Karuna Therapeutics, Inc. (NASDAQ: KRTX) had its "neutral" rating re-affirmed by analysts at Mizuho. They now have a $330.00 price target on the stock, up previously from $245.00.
1/26
08:45 am
krtx
Karuna Therapeutics, Inc. (NASDAQ: KRTX) had its "neutral" rating re-affirmed by analysts at Mizuho. They now have a $330.00 price target on the stock, up previously from $245.00.
Low
Report
Karuna Therapeutics, Inc. (NASDAQ: KRTX) had its "neutral" rating re-affirmed by analysts at Mizuho. They now have a $330.00 price target on the stock, up previously from $245.00.
1/26
05:57 am
krtx
Rating for KRTX
Low
Report
Rating for KRTX
1/26
05:57 am
krtx
Rating for KRTX
Low
Report
Rating for KRTX